Patient-Centricity taken seriously

The new article “PATIENT-CENTRICITY TAKEN SERIOUSLY” by Philipp Grätzel von Grätz in HIMSS INSIGHTS 8.2 features smart medication as a selected use case, among others.

Everybody talks about putting the patient in the driving seat. But connected care platforms that take this vision seriously continue to experience a hard time. How should patient-centricity be reimbursed?

…DIGITAL HEMOPHILIA PLATFORM OPTIMIZES USE OF EXPENSIVE CLOTTING FACTORS

“Given this background, there is a clear rationale for managing hemophilia patients with a digital platform. Doing so allows us to monitor compliance, and it also allows us to correlate bleeding events and medication in order to find the optimal dosing schedule for each individual patient,” says Andreas Rösch of Rösch & Associates, a Frankfurt-based company that is offering the digital haemophilia platform “smart medication.
(December 2019)

If you are interested in the article, feel free to contact us, or download the complete issue here, opens in a new tab.